Further studies are needed to precisely confirm the functional domain of LMP2A, which can down-regulate HER2, avoid LMP2A's own oncogenic potential, and serve as a potential target for treating gastric carcinoma with high HER2 expression. The gene discussed is ERBB2; the disease is gastric carcinoma.